|
US4886876A
(en)
|
1983-03-31 |
1989-12-12 |
Scripps Clinic And Research Foundation |
Factor VIII coagulant polypeptides
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
WO1985001961A1
(en)
|
1983-10-28 |
1985-05-09 |
Genetics Institute |
Production of factor viii and related products
|
|
US5045455A
(en)
|
1984-01-12 |
1991-09-03 |
Chiron Corporation |
Factor VIII:C cDNA cloning and expression
|
|
US4965199A
(en)
|
1984-04-20 |
1990-10-23 |
Genentech, Inc. |
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
|
|
FI86885C
(fi)
|
1984-04-20 |
1992-10-26 |
Genentech Inc |
Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
|
|
EP0182448A3
(en)
|
1984-08-24 |
1987-10-28 |
Genetics Institute, Inc. |
Production of factor viii and related products
|
|
FI98829C
(fi)
|
1986-01-27 |
1997-08-25 |
Chiron Corp |
Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
|
|
US5595886A
(en)
|
1986-01-27 |
1997-01-21 |
Chiron Corporation |
Protein complexes having Factor VIII:C activity and production thereof
|
|
US5451521A
(en)
|
1986-05-29 |
1995-09-19 |
Genetics Institute, Inc. |
Procoagulant proteins
|
|
US5422260A
(en)
|
1986-05-29 |
1995-06-06 |
Genetics Institute, Inc. -Legal Affairs |
Human factor VIII:c muteins
|
|
US5149637A
(en)
|
1987-04-06 |
1992-09-22 |
Scripps Clinic & Research Foundation |
Recombinant Factor VIIIC fragments
|
|
IL86693A
(en)
|
1987-06-12 |
1994-06-24 |
Stichting Centraal Lab |
Proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
|
|
FR2619314B1
(fr)
|
1987-08-11 |
1990-06-15 |
Transgene Sa |
Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
|
|
US5004803A
(en)
|
1988-11-14 |
1991-04-02 |
Genetics Institute, Inc. |
Production of procoagulant proteins
|
|
ZA909167B
(en)
|
1989-11-17 |
1993-10-15 |
Chiron Corp |
Protein complexes having Factor VIII:C activity and production thereof
|
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
|
SE468050C
(sv)
|
1991-03-15 |
1998-04-27 |
Pharmacia & Upjohn Ab |
Rekombinant derivat av human faktor VIII
|
|
US5661008A
(en)
|
1991-03-15 |
1997-08-26 |
Kabi Pharmacia Ab |
Recombinant human factor VIII derivatives
|
|
CA2078721A1
(en)
|
1991-09-24 |
1993-03-25 |
Hiroshi Yonemura |
Process for preparing human coagulation factor viii protein complex
|
|
WO1994011013A1
(en)
|
1992-11-13 |
1994-05-26 |
Duke University |
Chimeric blood coagulation proteins
|
|
US5563045A
(en)
|
1992-11-13 |
1996-10-08 |
Genetics Institute, Inc. |
Chimeric procoagulant proteins
|
|
DE69433925T2
(de)
|
1993-06-10 |
2005-07-28 |
Bayer Corp. |
Vektoren und Zelllinien von Säugetieren mit erhöhter Produktivität
|
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US5681746A
(en)
|
1994-12-30 |
1997-10-28 |
Chiron Viagene, Inc. |
Retroviral delivery of full length factor VIII
|
|
WO1997003195A1
(en)
|
1995-07-11 |
1997-01-30 |
Chiron Corporation |
Novel factor viii:c polypeptide analogs with altered protease sites
|
|
AU722624B2
(en)
|
1996-09-06 |
2000-08-10 |
Trustees Of The University Of Pennsylvania, The |
An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
|
|
US5948653A
(en)
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
|
CA2304168A1
(en)
|
1997-09-19 |
1999-04-01 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
CA2349838C
(en)
|
1998-11-05 |
2011-06-07 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6244113B1
(en)
|
1999-10-29 |
2001-06-12 |
University Of Alabama In Huntsville |
Method and apparatus for measuring microgravity acceleration
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
AU2002359284A1
(en)
|
2001-12-17 |
2003-06-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
|
|
GB0220936D0
(en)
*
|
2002-09-05 |
2002-10-23 |
Adprotech Ltd |
Modified therapeutic agents
|
|
US10501733B2
(en)
*
|
2015-02-27 |
2019-12-10 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
AU2018367670A1
(en)
*
|
2017-11-17 |
2020-05-07 |
Lonza Sales Ag |
Compositions of engineered exosomes and methods of loading luminal exosomes payloads
|
|
PT3672614T
(pt)
*
|
2018-11-16 |
2022-02-11 |
Codiak Biosciences Inc |
Vesículas extracelulares modificadas e suas utilizações
|